![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pixium Vision Reports Activation of Bionic Vision System
Pixium Vision Reports Activation of Bionic Vision System
![](https://www.fdanews.com/ext/resources/test/Drug-Images2/eye-drug.gif?t=1433908164&width=430)
Pixium Vision announced the successful activation of PRIMA, a miniaturized wireless photovoltaic sub-retinal implant, in a human with severe vision loss from age-related macular degeneration.
Lead investigator Yannick Le Mer, a pioneering ophthalmologist and retinal surgeon, said successful activation was achieved one-month post implantation as per the protocol. The patient reported a first perception of light from the central zone where there was none previously.
The implantation was part of a feasibility clinical study of PRIMA in France being conducted at Fondation Ophtalmologique Rothschild and Hôpital des Quinze-Vingt in Paris.
Upcoming Events
-
21Oct